期刊文献+

硝苯地平缓释片治疗高血压合并糖尿病的临床观察 被引量:2

下载PDF
导出
摘要 目的:硝苯地平缓释片对改善高血压合并糖尿病临床指标的效果观察。方法:抽取2013年8月-2014年8月期间在东莞市东坑镇社区卫生服务中心收治的高血压合并糖尿病患者74例,分为两组,给予对照组常规降糖及厄贝沙坦降压治疗,观察组在对照组基础上加用硝苯地平缓释片治疗,观察两组临床效果。结果:治疗后,观察组舒张压、收缩压下降程度,优于对照组,组间比较,差异具有统计学意义(P<0.05),观察组患者临床总有效率为94.59%,高于对照组的75.68%(P<0.05)。结论:硝苯地平缓释片能够有效改善高血压合并糖尿病的血压,提升治疗的疗效。
作者 廖彬
出处 《深圳中西医结合杂志》 2015年第10期136-137,共2页 Shenzhen Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献4

二级参考文献29

  • 1于海波,韩雅玲,王祖禄,张新娅,佟铭,许凤芝.替米沙坦降压疗效的临床研究[J].高血压杂志,2004,12(6):515-518. 被引量:21
  • 2Negro R, Formoso G, Hassan H. The effects of irbesartan and telmisar- tan on metabolic parameters and blood pressure in obese, insulin resist- ant, hypertensive patients [ J ]. J Endocrinol Invest,2006,29:957 -961.
  • 3Yamada S, Ano N, Toda K, et al. Telmisartan but not candesartan af- fects adiponectin expression in vivo and in vitro [ J ]. Hypertens Res, 200g 31 : 601-606.
  • 4World Health Organization. Definition, diagnosis and classifications of diabetes mellitus and its complications. Report of a WHO consultation, Partl : Diagnosis and classification of diabetes mellitus [ R ]. Geneva: WHO, 1999.
  • 5Andraws R, Brown DL. Effect of inhibition of the renin-angiotensin system on development of type 2 diabetes mellitus ( meta-analysis of randomized trims) [ J ]. Am J Cardiol, 2007, 99 : 1006-1012.
  • 6Inane T, Morooka T, Moroe K, et al. Effect of telmisartan on choles- terol levels in patients with hypertension: Saga Telmisartan Aggressive Research(STAR) [J]. Horm Metab Res , 2007, 39:372-376.
  • 7Mori Y, hob Y, Tajima N. Telmisartan improves lipid metabolism and adiponectin production but does not affect glycemic control in hyperten- sive patients with type 2 diabetes[J]. Adv Ther, 2007, 24:146-153.
  • 8Benson SC,Pershadsingh HA, Ho CI ,et al. Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPAR gam- ma-modulating activity[J]. Hypertension,2004,43 (5) :993-1002.
  • 9Clemenz M, Frost N, Schupp M, et al. Liver-specific peroxisome prolif- erator-activated receptor alpha target gene regulation by the angiotensin type 1 receptor blocker telmisartan[ J]. Diabetes ,2008,57 : 1405-1413.
  • 10Khann A,Hemmelgrn B,Herman J. The 2009 canadian hypertension education program recommendations for the management of hypertension:Part 2-therapy[J].{H}Canadian Journal of Cardiology,2009,(13):287-298.

共引文献41

同被引文献41

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部